Advertisement

Acute pain management and perioperative drugs used in low-resource settings

      Abstract

      The choice of drugs used during the perioperative period in low-resource settings is dictated by numerous factors. The lack of a reliable supply of essential medications coupled with limited provision of trained staff and necessary equipment are the main causative factors. Drugs used may be unfamiliar to anaesthetists from low-resource settings and those available can vary greatly from day to day. For this reason, it is important to develop an understanding of these drugs and their delivery. The management of acute pain benefits from a structured approach such as that used in the RAT model (recognise, assess, treat) from the Essential Pain Management course. This article provides an understanding of the choice of anaesthetic and analgesic drugs used in a low-resource setting with a focus on those used less commonly in a well-resourced setting.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Anaesthesia & Intensive Care Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Meara J.G.
        • Leather A.J.M.
        • Hagander L.
        • et al.
        Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.
        Lancet. 2015; 386: 569-624https://doi.org/10.1016/S0140-6736(15)60160-X
        • Mumphansha H.
        • Nickerson J.W.
        • Attaran A.
        • et al.
        An analysis of substandard propofol detected in use in Zambian anesthesia.
        Anesth Analg. 2017; 125: 616-619
        • Koritsanszky L.A.
        Continuous monitoring in global health: taking principles of anesthesia care Abroad: the lifebox model.
        J Anesth Hist. 2017; 3: 3-4https://doi.org/10.1016/j.janh.2016.12.005
        • Barbour R.
        • Deka P.
        Paediatric anaesthesia for low-resource settings.
        BJA Educ. 2017; 17: 351-356https://doi.org/10.1093/bjaed/mkx030
        • Royal College of Nursing
        Flow rate and IV drugs.
        RCN. 2019;
        • Green S.M.
        • Clem K.J.
        • Rothrock S.G.
        Ketamine safety profile in the developing world: survey of practitioners.
        Acad Emerg Med. 1996; 3: 598-604
        • Gales A.
        • Maxwell S.
        Ketamine: recent evidence and current uses. ATOTW 381. World Federation of Societies of Anaesthesiologists.
        12 June 2018
        • Coulter F.L.S.
        • Hannam J.A.
        • Anderson B.J.
        Ketofol simulations for dosing in pediatric anesthesia.
        Paediatr Anaesth. 2014; 24: 806-812
        • Smith S.
        • Smith E.
        • Sasada M.
        Drugs in anaesthesia and intensive care.
        4th Edition. Oxford University Press, 2011
        • Habibollahi P.
        • Mahboobi N.
        • Esmaeili S.
        • Safari S.
        • Dabbagh A.
        • Alavian S.M.
        Halothane-induced hepatitis: a forgotten issue in developing countries.
        Hepat Mon. 2011; 11: 3-6
        • Schnittger T.
        Regional anaesthesia in developing countries.
        Anaesthesia. 2007; 62: 44-47
        • Appiah-Ankam J.
        • Hunter J.M.
        Pharmacology of neuromuscular blocking drugs.
        Contin Educ Anaesth Crit Care Pain. February 2004; 4: 2-7https://doi.org/10.1093/bjaceaccp/mkh002
        • Durant N.N.
        • Katz R.L.
        Suxamethonium.
        Br J Anaesth. 1982; 54: 195
        • Nickerson J.W.
        • Pettus K.
        • Wheeler K.E.
        • et al.
        Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies.
        Can J Anaesth. 2017; 64 (Epub 2017 Jan 3): 296-307https://doi.org/10.1007/s12630-016-0805-9
        • Anis R.
        • Maclean L.
        • Kimena L.
        • Crichton L.
        Recovery facilities in a tertiary level hospital in Lusaka, Zambia.
        Br J Nursis. 2019; 28: 571-573https://doi.org/10.12968/bjon.2019.28.9.571
        • Seya M.J.
        • Gelders S.F.A.M.
        • Achara O.U.
        • et al.
        A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels.
        J Pain Palliat Care Pharmacother. 2011; 25: 6-18
        • Morriss W.W.
        • Roques C.J.
        Pain management in low- and middle-income countries.
        BJA Educ. 2018; 18: 265-270
      1. www.essentialpainmanagement.org

      2. International Association for the Study of Pain. Guide to pain management in low-resource settings.
        in: Kopf I.A. Patel N.B. IASP. 2010